PsyCan — the not-for-profit trade association of legally-operating Canadian psychedelic companies — is pleased to share its 2023 White Paper on the future of psychedelic access in Canada: Beyond the Special Access Program — Regulatory Analysis and Recommendations on Psychedelic Access in Canada.
The White Paper examines regulatory reforms governing access to psychedelics. It includes a review of current Canadian regulations and an environmental scan of relevant regulatory proposals, acts, and academic publications from comparable jurisdictions.
Written by a committee of PsyCan members, regulatory experts, and academics, the 2023 White Paper recommends a number of measures to reduce barriers for patients to access psychedelic-assisted therapies, including:
For inquiries, contact us at firstname.lastname@example.org.